NCT06658587

A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma

Clinical Study on the Accuracy of Novel Serological Risk Model in Early Diagnosis of Cholangiocarcinoma Patients

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 60 (estimated)
• Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

This is a prospective, observational and exploratory clinical study. The object of this study is to evaluate the accuracy of a novel serological risk model on blood samples in early diagnosis of cholangiocarcinoma patients.

Detailed description

A reliable and accurate preoperative tool capable of early diagnosing malignant cholangiocarcinoma is lacking and urgently needed for clinical practice. This study proposes to establish and evaluate a novel serological risk model on blood samples for non-invasively diagnosing cholangiocarcinoma. The study includes the construction of capable novel serological risk model and the validation of the diagnosis model.

Conditions

• Cholangiocarcinoma

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	No interventions	No interventions

Timeline

• Start date: 2024-11-01
• Primary completion: 2026-10-30
• Completion: 2027-10-30
• First posted: 2024-10-26
• Last updated: 2024-10-26

Locations

1 site across 1 country: China